Martin Dow
Platrid 75mg Tab 10s
60 Capsules
Rated 3.5 out of 5 (18)
Rs. 2,145
In Stock
-18%
Sanofi
Apixaget 5mg Tab 30s
Rated 4.0 out of 5 (32)SKU HP-00983
A tablet containing Apixaban, indicated for Stroke.
Rs. 810Rs. 990-18%
You save Rs. 180
200ml Syrup
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Apixaget 5mg Tab 30s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 810
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
How it works: Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa and prothrombinase activity. Apixaban has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting factor Xa, Apixaban prevents thrombin generation and thrombus development.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Active ingredient: Apixaban. Labelled strength: 5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Apixaget Healthcare (Pvt) Ltd.. Country of origin: Pakistan.
4.0
Rated 4.0 out of 532 verified ratings
- 5★0%
- 4★25%
- 3★75%
- 2★0%
- 1★0%
- Ayesha K.Verified Purchase4 Aug 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Rabia N.Verified Purchase24 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Zainab H.Verified Purchase11 Jul 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Fatima S.26 Jun 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
How it works: Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa and prothrombinase activity. Apixaban has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting factor Xa, Apixaban prevents thrombin generation and thrombus development.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Active ingredient: Apixaban. Labelled strength: 5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Apixaget Healthcare (Pvt) Ltd.. Country of origin: Pakistan.
4.0
Rated 4.0 out of 532 verified ratings
- 5★0%
- 4★25%
- 3★75%
- 2★0%
- 1★0%
- Ayesha K.Verified Purchase4 Aug 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Rabia N.Verified Purchase24 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Zainab H.Verified Purchase11 Jul 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Fatima S.26 Jun 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
SanofiApixaget 5mg Tab 30sRs. 810Rated 4.0 out of 5
Highnoon LabsJardin D 5mg Tablets 10sRs. 1,795Rated 4.5 out of 5
Highnoon LabsContour Capsules 20mgRs. 695Rated 4.5 out of 5
Bundle total
Rs. 3,300Rs. 3,775
Related concerns
Related reading
- Vitamin D Deficiency in Pakistan: Why It’s So Common
7 min read · Hope Pharmacy Wellness Team
- Perimenopause: Signs That Start in Your Late 30s
7 min read · Dr. Ayesha Siddiqui
- UTI Symptoms, Causes and Prevention: A Complete Guide
8 min read · Dr. Ayesha Siddiqui
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in OTC And Health Need